BioSpace News Archive

Medicine-On-Time, LLC (Medicine-On-Time) announced today the release of three new medication management products.

Agency responds to citizen petition, announces agreements with universities, updates bulks categories and schedules advisory committee meeting

Teva’s Copaxone remains the brand share leader among new start patients year-over-year, although neurologists are beginning to write prescriptions for Mylan’s generic glatiramer acetate and Sandoz’s Glatopa independent of direct payer influence, according to a recently published independent audit from Spherix Global Insights

In a new study published in Nutrients titled “Lutein and Zeaxanthin Isomers Protect Against Light-induced Retinopathy via Decreasing Oxidative and Endoplasmic Reticulum Stress in BALB/cJ Mice,” Lutemax 2020 supplementation was shown to protect photoreceptors against blue light damage by mitigating oxidative and endoplasmic reticulum stress

Rowley Law PLLC is investigating potential claims against LifePoint Health, Inc. (NASDAQ: LPNT) and its board of directors for breach of fiduciary duty concerning the proposed acquisition of the company by Apollo Global Management.

Once combined, the two entities will create one of the five largest Catholic health care systems in the nation, with more than 57,000 employees and 1,000 sites of care

Cellerant Therapeutics, Inc., a clinical-stage company developing innovative immunotherapies for hematologic malignancies and other blood-related disorders, announced the publication of preclinical data demonstrating the potential of CLT030,the Company’s CLL1-targeting...

New research advances the diagnosis of concussions and PTSD for those in the line of duty

Community health champion and public health social worker tapped to expand non-profit’s efforts in dismantling barriers to health equity

Ophthalmologist and Clinical Instructor Plans to Make Board Certification More Cost-Effective, Technologically Advanced